Today: 21 May 2026
WiseTech Global (ASX:WTC) share price hits 52-week low as inflation shock fuels rate-hike bets
28 January 2026
1 min read

WiseTech Global (ASX:WTC) share price hits 52-week low as inflation shock fuels rate-hike bets

Sydney, January 28, 2026, 17:42 AEDT — Trading has wrapped up for the day.

WiseTech Global Ltd shares fell 3.8% on Wednesday, ending the day at A$60.70 after touching a 52-week low of A$60.43 earlier. The drop wiped out Tuesday’s 1.9% gain.

The drop has become notable as traders rethink the interest-rate outlook, and high-growth software names like WiseTech usually suffer when investors demand bigger returns sooner.

Australia’s trimmed-mean consumer price index, which strips out volatile price swings, rose 0.9% in the December quarter and 3.4% year-on-year, according to Reuters. Swaps markets are pricing in a 73% chance the Reserve Bank of Australia will hike rates at its Feb. 3 meeting. “Demand is running ahead of supply,” said Adam Boyton, head of Australian economics at ANZ. EY’s chief economist Cherelle Murphy said the “case for tighter monetary policy is clear.” Reuters

The S&P/ASX 200 closed down 0.09%, dragged lower by declines in IT as well as healthcare and consumer discretionary stocks, per Investing.com data.

Sharecafe reported the tech sector fell nearly 2%, weighed down by declines in WiseTech and accounting software company Xero.

Westpac chief economist Luci Ellis called the inflation number the “casting vote” for a rate hike, but she hinted the move might not trigger a prolonged series of increases, The Edge Malaysia reported. The Edge Malaysia

WiseTech’s CargoWise platform helps freight forwarders and logistics companies manage shipments and compliance across supply chains. The stock, popular among Australian investors, frequently serves as a gauge for risk appetite in the local tech scene because of its sharp price swings.

With no fresh company updates on Wednesday, investors are zeroing in on macro cues and positioning ahead of February earnings. For WiseTech, watch for guidance and comments on customer demand and cost patterns.

The rate story cuts both ways. If inflation stays elevated and the RBA signals more tightening, expect high-multiple software stocks to slide further; a softer inflation outlook could relieve some of that pressure.

WiseTech will release its half-year results on Feb. 25, a date investors are circling. Ahead of that, attention turns to next week’s RBA decision for signals on interest rate moves.

Stock Market Today

  • Sharda Cropchem Earnings Reveal Weak Cash Flow Despite Profit Growth
    May 20, 2026, 9:35 PM EDT. Sharda Cropchem Limited's (NSE:SHARDACROP) recent earnings report shows a statutory profit of ₹6.81 billion for the year ending March 2026, but free cash flow was significantly lower at ₹1.6 billion, resulting in a high accrual ratio of 0.23. This suggests the company's cash conversion is less than ideal, raising concerns about the sustainability of its earnings. Despite this, Sharda Cropchem's earnings per share (EPS) has grown impressively over the past three years. Investors remain cautious due to three warning signs surrounding the stock, with one marked as significant. The gap between profit and cash flow indicates that reported profits may overstate the company's underlying earning power.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Santos shares climb again as Barossa milestone lands — what STO investors watch next
Previous Story

Santos shares climb again as Barossa milestone lands — what STO investors watch next

IAG share price slips as oil climbs again; investors brace for British Airways owner’s results
Next Story

IAG share price slips as oil climbs again; investors brace for British Airways owner’s results

Go toTop